Please contact us at least 3 weeks before the submission deadline.
This enables us to provide qualitative advice and support.
The open calls are sorted by submission deadline.
VLAIO – International ITEA-call 2025 and match making event
ITEA is an industry-driven European ecosystem for collaborative R&D projects on software-intensive systems. ITEA projects cover all topics related to software innovation, including:
- Artificial intelligence (e.g. large language models and other generative AI)
- Smart healthcare
- Cybersecurity (digital safety and security)
- Industry 4.0 and smart engineering, including simulation tools, digital twins, robotics and IoT
- Sustainability, including smart mobility and smart cities
Participating countries include Austria, Belgium (Flanders: VLAIO; Brussels: Innoviris; Wallonia: SPW), Canada, the Czech Republic, Germany, Denmark, Spain, Estonia, Finland, France, the United Kingdom, Hungary, South Korea, Lithuania, the Netherlands, Portugal, Romania, Sweden and Turkey.
Deadline: 10 November 2025 (concept); 29 May 2026 (full proposal)
KOTK – Upcoming call: Inter-local call – Advancing Clinical Research in Local Cancer Treatments
The call will officially open in December 2025. Detailed information on eligibility, guidelines, and application procedures will be published on the dedicated call website in the coming months. A webinar and Q&A session will also be organised to support prospective applicants.
EU – ERA4Health Partnership – Call PREVENT-OO ‘Understanding and Preventing Overweight and Obesity’
Focus on mechanisms of their onset and progression, neglected determinants and novel strategies for critical transitional periods in life. Applications must cover only one of the two following topics:
- Research that improves the understanding of the causes for obesity, overweight and its complications by using a mechanistic approach.
- Research that focuses on prevention and public health strategies for critical transitional periods of life.
Deadline: 21 January 2026 (pre-proposal), 11 June 2026 (full proposal)
Leukemia Research Foundation
The application portal for the 2025 funding cycle is now open! Grants of up to $150K over a two-year period are available to early career investigators -- researchers within seven years after their first independent faculty-level position.
Making progress in treating and ultimately curing leukemia and MDS requires advances across the research continuum – from understanding the fundamental biology of cancer cells to preventing relapse after treatment. All projects that help move the field forward toward a better understanding of the diseases, improved symptom management and more effective treatment will be considered.
Budget: $150.000
Deadline: 6 February 2026 (LOI); 13 April 2026 (full proposal)
EU – EP PerMed Joint Transnational Call (JTC) 2026 – Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
Deadline: 10 February 2026 (pre-proposal), 9 June 2026 (full proposal)
EU – ERDERA – Joint Transnational Call 2026
On 10 December 2025, ERDERA will launch its 2026 Joint Transnational Call, “Resolving unsolved cases in rare genetic and non‑genetic diseases through variant validation and new technological approaches”.
The call will welcome proposals focused on providing diagnostic clarity in unsolved rare genetic and non‑genetic diseases.
This call’s pre‑announcement is available below, and it describes the forthcoming opportunity for multinational research teams to apply and will be updated with the full call when it launches.
Involving patient organisations from the very start is highly desirable. Should you need guidance about patient involvement in research, have a look at this guide.
Deadline: 12 February 2026 (pre-proposal); 8 July 2026 (full proposal)
FWO – Research project Kom op tegen Kanker
In the context of the ‘Kom op tegen Kanker’ campaign, the FWO has a yearly budget of € 1,645,000 available (overhead excluded), to support patient-oriented research projects with a specific scope. For the 2026 call, the scope is: “Patient-oriented research that aims to improve the quality of life of (ex-)cancer patients during and after cancer treatment, by responding to their physical, mental and/or social needs. The research is conducted in co-creation with the target group and focuses on developing and providing new scientifically substantiated evidence that is of high quality and applicable in practice.”
With this call, the FWO supports patient-oriented research. Therefore, patient representatives have a voice in decision making. The scientific experts of the FWO jury and the members of the KOTK patient committee will select by consensus scientifically excellent, patient-oriented project proposals for financing.
Deadline: 01 April 2026
FWO – BE READY Joint Transnational Call 2026
The European Partnership for Pandemic Preparedness (BE READY Partnership) aims to establish a European research and innovation ecosystem that is optimally prepared for future health crises caused by infectious diseases. This ecosystem will be capable of responding swiftly and efficiently to such crises and will be fully integrated into the broader European institutional framework for health security.
Deadline: 13 April 2026 (pre-proposal); 20 August 2026 (full proposal)
King Baudouin Foundation – Prize Generet for rare diseases
The call is aimed to two categories of researchers: confirmed researchers in rare diseases and confirmed researchers with a track record in more common pathologies who can demonstrate that their research will have a substantial added value for rare diseases and can accelerate research in this particular field.
International and interdisciplinary collaboration are strongly encouraged.
Budget: 1.250.000 euro
Deadline: 20 April 2026
This list is non-exhaustive